130 related articles for article (PubMed ID: 12393227)
1. Behavioural and histopathological analyses of ibuprofen treatment on the effect of aggregated Abeta(1-42) injections in the rat.
Richardson RL; Kim EM; Shephard RA; Gardiner T; Cleary J; O'Hare E
Brain Res; 2002 Nov; 954(1):1-10. PubMed ID: 12393227
[TBL] [Abstract][Full Text] [Related]
2. Behavioural deterioration induced by intrahippocampal NAC61-95 injections and attenuation with ibuprofen.
O'Hare E; Elliott JJ; Hobson P; Spanswick D; Kim EM
Behav Brain Res; 2010 Mar; 208(1):274-7. PubMed ID: 19931572
[TBL] [Abstract][Full Text] [Related]
3. Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42).
O'Hare E; Weldon DT; Mantyh PW; Ghilardi JR; Finke MP; Kuskowski MA; Maggio JE; Shephard RA; Cleary J
Brain Res; 1999 Jan; 815(1):1-10. PubMed ID: 9974116
[TBL] [Abstract][Full Text] [Related]
4. Chronic intracerebroventricular infusion of lipopolysaccharide: effects of ibuprofen treatment and behavioural and histopathological correlates.
Richardson RL; Kim EM; Gardiner T; O'Hare E
Behav Pharmacol; 2005 Nov; 16(7):531-41. PubMed ID: 16170230
[TBL] [Abstract][Full Text] [Related]
5. Effects of intrahippocampal NAC 61-95 injections on memory in the rat and attenuation with vitamin E.
Kim EM; Elliot JJ; Hobson P; O'Hare E
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):945-51. PubMed ID: 19410626
[TBL] [Abstract][Full Text] [Related]
6. Novel anti-inflammatory compound SEN1176 alleviates behavioral deficits induced following bilateral intrahippocampal injection of aggregated amyloid-β₁₋₄₂.
O'Hare E; Scopes DI; Treherne JM; Monaghan J; Palmer PM; Amijee H; Kim EM
J Alzheimers Dis; 2011; 25(2):219-29. PubMed ID: 21654060
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
8. NOS-mediated morphological and molecular modifications in rats infused with Aβ (1-40), as a model of Alzheimer's disease, in response to a new lipophilic molecular combination codrug-1.
Zara S; Di Stefano A; Nasuti C; Rapino M; Patruno A; Pesce M; Sozio P; Cerasa LS; Cataldi A
Exp Gerontol; 2011 Apr; 46(4):273-81. PubMed ID: 21070848
[TBL] [Abstract][Full Text] [Related]
9. Bilateral intrahippocampal NAC61-95 effects on behavior and moderation with L-NAME treatment.
O'Hare E; Elliott JJ; Hobson P; O'Mara SM; Spanswick D; Kim EM
Neurosci Res; 2010 Feb; 66(2):213-8. PubMed ID: 19913060
[TBL] [Abstract][Full Text] [Related]
10. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.
Morihara T; Teter B; Yang F; Lim GP; Boudinot S; Boudinot FD; Frautschy SA; Cole GM
Neuropsychopharmacology; 2005 Jun; 30(6):1111-20. PubMed ID: 15688088
[TBL] [Abstract][Full Text] [Related]
11. Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease.
Pinnen F; Sozio P; Cacciatore I; Cornacchia C; Mollica A; Iannitelli A; D'Aurizio E; Cataldi A; Zara S; Nasuti C; Di Stefano A
Arch Pharm (Weinheim); 2011 Mar; 344(3):139-48. PubMed ID: 21384412
[TBL] [Abstract][Full Text] [Related]
12. Beta-amyloid(1-40) effects on behavior and memory.
Cleary J; Hittner JM; Semotuk M; Mantyh P; O'Hare E
Brain Res; 1995 Jun; 682(1-2):69-74. PubMed ID: 7552329
[TBL] [Abstract][Full Text] [Related]
13. No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease.
Hillmann A; Hahn S; Schilling S; Hoffmann T; Demuth HU; Bulic B; Schneider-Axmann T; Bayer TA; Weggen S; Wirths O
Neurobiol Aging; 2012 Apr; 33(4):833.e39-50. PubMed ID: 21943956
[TBL] [Abstract][Full Text] [Related]
14. Intensity-dependent effects of repetitive anodal transcranial direct current stimulation on learning and memory in a rat model of Alzheimer's disease.
Yu X; Li Y; Wen H; Zhang Y; Tian X
Neurobiol Learn Mem; 2015 Sep; 123():168-78. PubMed ID: 26070657
[TBL] [Abstract][Full Text] [Related]
15. Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35).
Stepanichev MY; Zdobnova IM; Yakovlev AA; Onufriev MV; Lazareva NA; Zarubenko II; Gulyaeva NV
J Neurosci Res; 2003 Jan; 71(1):110-20. PubMed ID: 12478619
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
Sharma S; Verma S; Kapoor M; Saini A; Nehru B
Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
[TBL] [Abstract][Full Text] [Related]
17. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology.
Frautschy SA; Hu W; Kim P; Miller SA; Chu T; Harris-White ME; Cole GM
Neurobiol Aging; 2001; 22(6):993-1005. PubMed ID: 11755008
[TBL] [Abstract][Full Text] [Related]
18. Amyloid beta(1-40)-induced astrogliosis and the effect of genistein treatment in rat: a three-dimensional confocal morphometric and proteomic study.
Bagheri M; Rezakhani A; Nyström S; Turkina MV; Roghani M; Hammarström P; Mohseni S
PLoS One; 2013; 8(10):e76526. PubMed ID: 24130779
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).
Miguel-Hidalgo JJ; Alvarez XA; Cacabelos R; Quack G
Brain Res; 2002 Dec; 958(1):210-21. PubMed ID: 12468047
[TBL] [Abstract][Full Text] [Related]
20. Soluble oligomeric forms of beta-amyloid (Abeta) peptide stimulate Abeta production via astrogliosis in the rat brain.
Perez JL; Carrero I; Gonzalo P; Arevalo-Serrano J; Sanz-Anquela JM; Ortega J; Rodriguez M; Gonzalo-Ruiz A
Exp Neurol; 2010 Jun; 223(2):410-21. PubMed ID: 19879263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
